Beginning Jan. 1, Exact Sciences’ Cologuard will be included for Humana members, the company announced today.

Humana has nearly 10 million beneficiaries and is the nation’s fifth largest commercial insurer.

“As demand for Cologuard grows, this contract marks an opportunity to increase access to colon cancer screening among Humana’s beneficiaries who now can choose Cologuard and its wrap-around compliance service,” Exact Sciences CEO Kevin Conroy said in a statement. “We believe this decision by one of the nation’s largest health insurers reflects a growing understanding that Cologuard can detect more cancers earlier and reduce costs in the health system.”

According to a release, Cologuard will be available to most Humana beneficiaries with no co-pay. The colon-cancer screening device is now covered for more than 153 million people.